During the past decade, Narodny ustav reumatickych chorob conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 10 clinical trials were completed, i.e. on average, 333.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Narodny ustav reumatickych chorob" #1 sponsor was "Pfizer" with 10 trials, followed by "Amgen" with 2 trials sponsored, "Human Genome Sciences Inc." with 1 trials sponsored, "IBSA Institut Biochimique SA" with 1 trials sponsored and "Vertex Pharmaceuticals Incorporated" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Narodny ustav reumatickych chorob" #1 collaborator was "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Narodny ustav reumatickych chorob" are "Arthritis, Rheumatoid" (2 trials), "Juvenile Idiopathic Arthritis" (2 trials), "Psoriatic Arthritis" (2 trials), "Rheumatoid Arthritis" (2 trials) and "Ankylosing Spondyloarthritis" (1 trials). Many other conditions were trialed in "Narodny ustav reumatickych chorob" in a lesser frequency.

Most popular intervention types in "Narodny ustav reumatickych chorob" are "Drug" (14 trials), "Other" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "CP-690,550" (3 trials), "Tofacitinib" (2 trials), "Apremilast 20mg" (1 trials) and "Apremilast 30mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Narodny ustav reumatickych chorob" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Narodny ustav reumatickych chorob". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Narodny ustav reumatickych chorob, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Narodny ustav reumatickych chorob, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".